0000899243-22-026768.txt : 20220726
0000899243-22-026768.hdr.sgml : 20220726
20220726201502
ACCESSION NUMBER: 0000899243-22-026768
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220725
FILED AS OF DATE: 20220726
DATE AS OF CHANGE: 20220726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brandenberger Ralph
CENTRAL INDEX KEY: 0001853197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 221108560
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 102
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-582-4923
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-25
0
0001787400
Nkarta, Inc.
NKTX
0001853197
Brandenberger Ralph
C/O NKARTA, INC.,
6000 SHORELINE COURT, SUITE 102
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Technical Officer
Common Stock
2022-07-25
4
M
0
3000
0.41
A
10800
D
Common Stock
2022-07-25
4
S
0
3000
13.4101
D
7800
D
Stock Option (right to buy)
0.41
2022-07-25
4
M
0
3000
0.00
D
2028-07-18
Common Stock
3000
4367
D
The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person at least 30 days prior to the trade date.
This transaction was executed in multiple trades at prices ranging from $13.29 to $13.59. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This stock option is fully vested.
/s/ Alicia Hager, as Attorney-in-Fact
2022-07-26